STAT3 and diabetes mellitus: Specifically, a major contribution of our work is the proposal of RAGE-JAK2-STAT3 as a novel therapeutic target that would influence the mitochondrial dynamics and restore normal mitochondrial function and prevent vascular complications in diabetes.